Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Pettilä V[au]:

Fluid management in acute kidney injury. Perner A et al. Intensive Care Med. (2017)

Renal recovery after acute kidney injury. Forni LG et al. Intensive Care Med. (2017)

Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial. Vincent JL et al. JAMA. (2019)

Search results

Items: 1 to 50 of 270

1.

Association of endothelial and glycocalyx injury biomarkers with fluid administration, development of acute kidney injury, and 90-day mortality: data from the FINNAKI observational study.

Inkinen N, Pettilä V, Lakkisto P, Kuitunen A, Jukarainen S, Bendel S, Inkinen O, Ala-Kokko T, Vaara ST; FINNAKI Study Group.

Ann Intensive Care. 2019 Sep 11;9(1):103. doi: 10.1186/s13613-019-0575-y.

2.

No Association Between Genetic Loci Near IRF2 and TBX1 and Acute Kidney Injury in the Critically Ill.

Renken IJ, Vilander LM, Kaunisto MA, Vaara ST, Snieder H, Keus F, Van Der Horst ICC, Pettilä V; FINNAKI investigators and the HEALICS consortium.

Am J Respir Crit Care Med. 2019 Sep 5. doi: 10.1164/rccm.201903-0633LE. [Epub ahead of print] No abstract available.

PMID:
31487200
3.

The association of endothelial injury and systemic inflammation with perioperative myocardial infarction.

Ollila A, Vikatmaa L, Virolainen J, Nisula S, Lakkisto P, Vikatmaa P, Tikkanen I, Venermo M, Pettilä V.

Ann Clin Biochem. 2019 Sep 4:4563219873357. doi: 10.1177/0004563219873357. [Epub ahead of print] No abstract available.

PMID:
31409092
4.

Clinical Examination for the Prediction of Mortality in the Critically Ill: The Simple Intensive Care Studies-I.

Hiemstra B, Eck RJ, Wiersema R, Kaufmann T, Koster G, Scheeren TWL, Snieder H, Perner A, Pettilä V, Wetterslev J, Keus F, van der Horst ICC; SICS Study Group.

Crit Care Med. 2019 Oct;47(10):1301-1309. doi: 10.1097/CCM.0000000000003897.

5.

Neutrophil activation in septic acute kidney injury: A post hoc analysis of the FINNAKI study.

Törnblom S, Nisula S, Vaara ST, Poukkanen M, Andersson S, Pettilä V, Pesonen E.

Acta Anaesthesiol Scand. 2019 Nov;63(10):1390-1397. doi: 10.1111/aas.13451. Epub 2019 Aug 6.

PMID:
31325317
6.

Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan.

Meyhoff TS, Hjortrup PB, Møller MH, Wetterslev J, Lange T, Kjaer MN, Jonsson AB, Hjortsø CJS, Cronhjort M, Laake JH, Jakob SM, Nalos M, Pettilä V, van der Horst I, Ostermann M, Mouncey P, Rowan K, Cecconi M, Ferrer R, Malbrain MLNG, Ahlstedt C, Hoffmann S, Bestle MH, Nebrich L, Russell L, Vang M, Rasmussen ML, Sølling C, Rasmussen BS, Brøchner AC, Perner A.

Acta Anaesthesiol Scand. 2019 Oct;63(9):1262-1271. doi: 10.1111/aas.13434. Epub 2019 Jul 24.

PMID:
31276193
7.

Heme oxygenase-1 repeat polymorphism in septic acute kidney injury.

Vilander LM, Vaara ST, Donner KM, Lakkisto P, Kaunisto MA, Pettilä V; FINNAKI Study Group.

PLoS One. 2019 May 23;14(5):e0217291. doi: 10.1371/journal.pone.0217291. eCollection 2019.

8.

The origin of plasma neutrophil gelatinase-associated lipocalin in cardiac surgery.

Passov A, Petäjä L, Pihlajoki M, Salminen US, Suojaranta R, Vento A, Andersson S, Pettilä V, Schramko A, Pesonen E.

BMC Nephrol. 2019 May 22;20(1):182. doi: 10.1186/s12882-019-1380-4.

9.

Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial.

Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, Pettilä V, Wittebole X, Meziani F, Mercier E, Lobo SM, Barie PS, Crowther M, Esmon CT, Fareed J, Gando S, Gorelick KJ, Levi M, Mira JP, Opal SM, Parrillo J, Russell JA, Saito H, Tsuruta K, Sakai T, Fineberg D; SCARLET Trial Group.

JAMA. 2019 May 28;321(20):1993-2002. doi: 10.1001/jama.2019.5358.

PMID:
31104069
10.

Near-infrared spectroscopy after out-of-hospital cardiac arrest.

Jakkula P, Hästbacka J, Reinikainen M, Pettilä V, Loisa P, Tiainen M, Wilkman E, Bendel S, Birkelund T, Pulkkinen A, Bäcklund M, Heino S, Karlsson S, Kopponen H, Skrifvars MB.

Crit Care. 2019 May 14;23(1):171. doi: 10.1186/s13054-019-2428-3.

11.

Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC.

Wihersaari L, Tiainen M, Skrifvars MB, Bendel S, Kaukonen KM, Vaahersalo J, Romppanen J, Pettilä V, Reinikainen M; FINNRESUSCI study group.

Resuscitation. 2019 Jun;139:214-221. doi: 10.1016/j.resuscitation.2019.04.021. Epub 2019 Apr 22.

PMID:
31022497
12.

Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca2+-Dependent Arrhythmia.

Ottesen AH, Carlson CR, Eken OS, Sadredini M, Myhre PL, Shen X, Dalhus B, Laver DR, Lunde PK, Kurola J, Lunde M, Hoff JE, Godang K, Sjaastad I, Pettilä V, Stridsberg M, Lehnart SE, Edwards AG, Lunde IG, Omland T, Stokke MK, Christensen G, Røsjø H, Louch WE.

Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e007045. doi: 10.1161/CIRCEP.118.007045.

PMID:
30943765
13.

Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.

Knott RJ, Harris A, Higgins A, Nichol A, French C, Little L, Haddad S, Presneill J, Arabi Y, Bailey M, Cooper DJ, Duranteau J, Huet O, Mak A, McArthur C, Pettilä V, Skrifvars MB, Vallance S, Varma D, Wills J, Bellomo R.

J Neurotrauma. 2019 Sep 1;36(17):2541-2548. doi: 10.1089/neu.2018.6229. Epub 2019 May 23.

PMID:
30907230
14.

Associations between tricuspid annular plane systolic excursion to reflect right ventricular function and acute kidney injury in critically ill patients: a SICS-I sub-study.

Wiersema R, Koeze J, Hiemstra B, Pettilä V, Perner A, Keus F, van der Horst ICC; SICS Study Group.

Ann Intensive Care. 2019 Mar 13;9(1):38. doi: 10.1186/s13613-019-0513-z.

15.

Common Inflammation-Related Candidate Gene Variants and Acute Kidney Injury in 2647 Critically Ill Finnish Patients.

Vilander LM, Vaara ST, Kaunisto MA, Pettilä V, Study Group TF.

J Clin Med. 2019 Mar 11;8(3). pii: E342. doi: 10.3390/jcm8030342.

16.

NSE concentrations and haemolysis after cardiac arrest.

Jakkula P, Skrifvars MB, Pettilä V, Hästbacka J, Reinikainen M.

Intensive Care Med. 2019 May;45(5):741-742. doi: 10.1007/s00134-019-05547-8. Epub 2019 Feb 13. No abstract available.

PMID:
30758520
17.

Circulating Secretoneurin Concentrations After Cardiac Surgery: Data From the FINNish Acute Kidney Injury Heart Study.

Brynildsen J, Petäjä L, Myhre PL, Lyngbakken MN, Nygård S, Stridsberg M, Christensen G, Ottesen AH, Pettilä V, Omland T, Røsjø H.

Crit Care Med. 2019 May;47(5):e412-e419. doi: 10.1097/CCM.0000000000003670.

PMID:
30730440
18.

Red blood cell transfusion in southern Finland from 2011 to 2016: a quality audit.

Laurén E, Vikatmaa L, Kerkelä E, Kivipuro T, Krusius T, Syrjälä M, Ihalainen J, Pettilä V.

Transfus Med. 2019 Feb;29(1):41-47. doi: 10.1111/tme.12568. Epub 2018 Dec 6.

PMID:
30523663
19.

Focus on randomised clinical trials.

Perner A, Hjortrup PB, Pettilä V.

Intensive Care Med. 2018 Dec;44(12):2257-2259. doi: 10.1007/s00134-018-5468-2. Epub 2018 Nov 15. No abstract available.

PMID:
30443730
20.

Targeting low-normal or high-normal mean arterial pressure after cardiac arrest and resuscitation: a randomised pilot trial.

Jakkula P, Pettilä V, Skrifvars MB, Hästbacka J, Loisa P, Tiainen M, Wilkman E, Toppila J, Koskue T, Bendel S, Birkelund T, Laru-Sompa R, Valkonen M, Reinikainen M; COMACARE study group.

Intensive Care Med. 2018 Dec;44(12):2091-2101. doi: 10.1007/s00134-018-5446-8. Epub 2018 Nov 15.

21.

Targeting two different levels of both arterial carbon dioxide and arterial oxygen after cardiac arrest and resuscitation: a randomised pilot trial.

Jakkula P, Reinikainen M, Hästbacka J, Loisa P, Tiainen M, Pettilä V, Toppila J, Lähde M, Bäcklund M, Okkonen M, Bendel S, Birkelund T, Pulkkinen A, Heinonen J, Tikka T, Skrifvars MB; COMACARE study group.

Intensive Care Med. 2018 Dec;44(12):2112-2121. doi: 10.1007/s00134-018-5453-9. Epub 2018 Nov 14.

22.

Efficacy and safety of intravenous esmolol for cardiac protection in non-cardiac surgery. A systematic review and meta-analysis.

Ollila A, Vikatmaa L, Sund R, Pettilä V, Wilkman E.

Ann Med. 2019 Feb;51(1):17-27. doi: 10.1080/07853890.2018.1538565. Epub 2018 Nov 26.

PMID:
30346213
23.

One- and three-year outcomes in patients treated with intermittent hemodialysis for acute kidney injury: prospective observational multicenter post-hoc FINNAKI study.

Eskola M, Vaara ST, Korhonen AM, Sauranen J, Koivuviita N, Honkanen E, Pettilä V, Haapio M; FINNAKI Study Group.

Acta Anaesthesiol Scand. 2018 Nov;62(10):1452-1459. doi: 10.1111/aas.13203. Epub 2018 Jul 6.

PMID:
29978569
24.

Premorbid functional status as a predictor of 1-year mortality and functional status in intensive care patients aged 80 years or older.

Pietiläinen L, Hästbacka J, Bäcklund M, Parviainen I, Pettilä V, Reinikainen M.

Intensive Care Med. 2018 Aug;44(8):1221-1229. doi: 10.1007/s00134-018-5273-y. Epub 2018 Jul 2.

PMID:
29968013
25.

Surviving out-of-hospital cardiac arrest: The neurological and functional outcome and health-related quality of life one year later.

Tiainen M, Vaahersalo J, Skrifvars MB, Hästbacka J, Grönlund J, Pettilä V.

Resuscitation. 2018 Aug;129:19-23. doi: 10.1016/j.resuscitation.2018.05.011. Epub 2018 May 15.

PMID:
29775641
26.

Lower heart rate is associated with good one-year outcome in post-resuscitation patients.

Oksanen T, Tiainen M, Vaahersalo J, Bendel S, Varpula T, Skrifvars M, Pettilä V, Wilkman E; FINNRESUSCI Study Group.

Resuscitation. 2018 Jul;128:112-118. doi: 10.1016/j.resuscitation.2018.05.001. Epub 2018 May 5.

PMID:
29733922
27.

Expert statement for the management of hypovolemia in sepsis.

Perner A, Cecconi M, Cronhjort M, Darmon M, Jakob SM, Pettilä V, van der Horst ICC.

Intensive Care Med. 2018 Jun;44(6):791-798. doi: 10.1007/s00134-018-5177-x. Epub 2018 Apr 25. Review.

PMID:
29696295
28.

The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency.

Laake JH, Tønnessen TI, Chew MS, Lipcsey M, Hjelmqvist H, Wilkman E, Pettilä V, Hoffmann-Petersen J, Møller MH; Board of the Scandinavian Society of Anaesthesiology Intensive Care Medicine (SSAI).

Acta Anaesthesiol Scand. 2018 Jul;62(6):874-875. doi: 10.1111/aas.13120. Epub 2018 Apr 16. No abstract available.

29.

Early Lactate Values After Out-of-Hospital Cardiac Arrest: Associations With One-Year Outcome.

Laurikkala J, Skrifvars MB, Bäcklund M, Tiainen M, Bendel S, Karhu J, Varpula T, Vaahersalo J, Pettilä V, Wilkman E; FINNRESUSCI study group.

Shock. 2019 Feb;51(2):168-173. doi: 10.1097/SHK.0000000000001145.

PMID:
29608551
30.

The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients.

Brynildsen J, Petäjä L, Pettilä V, Nygård S, Vaara ST, Linko R, Okkonen M, Hagve TA, Soininen L, Suojaranta-Ylinen R, Lyngbakken MN, Omland T, Røsjø H.

Clin Biochem. 2018 Mar;53:65-71. doi: 10.1016/j.clinbiochem.2018.01.012. Epub 2018 Jan 31.

PMID:
29371002
31.

Procalcitonin and Presepsin as Prognostic Markers After Out-of-Hospital Cardiac Arrest.

Pekkarinen PT, Ristagno G, Wilkman E, Masson S, Latini R, Laurikkala J, Bendel S, Ala-Kokko T, Varpula T, Vaahersalo J, Karlsson S, Tiainen M, Mion MM, Plebani M, Pettilä V, Skrifvars MB; FINNRESUSCI Study Group.

Shock. 2018 Oct;50(4):395-400. doi: 10.1097/SHK.0000000000001087.

PMID:
29251667
32.

Signalling Profiles of Blood Leucocytes in Sepsis and in Acute Pancreatitis in Relation to Disease Severity.

Kuuliala K, Penttilä AK, Kaukonen KM, Mustonen H, Kuuliala A, Oiva J, Hämäläinen M, Moilanen E, Pettilä V, Puolakkainen P, Kylänpää L, Repo H.

Scand J Immunol. 2018 Feb;87(2):88-98. doi: 10.1111/sji.12630. Epub 2017 Dec 12.

33.

Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial.

Bellingan G, Brealey D, Mancebo J, Mercat A, Patroniti N, Pettilä V, Quintel M, Vincent JL, Maksimow M, Jalkanen M, Piippo I, Ranieri VM.

Trials. 2017 Nov 13;18(1):536. doi: 10.1186/s13063-017-2234-7.

34.

Targeting low- or high-normal Carbon dioxide, Oxygen, and Mean arterial pressure After Cardiac Arrest and REsuscitation: study protocol for a randomized pilot trial.

Jakkula P, Reinikainen M, Hästbacka J, Pettilä V, Loisa P, Karlsson S, Laru-Sompa R, Bendel S, Oksanen T, Birkelund T, Tiainen M, Toppila J, Hakkarainen A, Skrifvars MB; COMACARE study group.

Trials. 2017 Oct 30;18(1):507. doi: 10.1186/s13063-017-2257-0.

35.

Heparin-binding protein (HBP) improves prediction of sepsis-related acute kidney injury.

Tverring J, Vaara ST, Fisher J, Poukkanen M, Pettilä V, Linder A; FINNAKI Study Group.

Ann Intensive Care. 2017 Oct 18;7(1):105. doi: 10.1186/s13613-017-0330-1.

36.

Focus on fluid therapy.

Perner A, Hjortrup PB, Pettilä V.

Intensive Care Med. 2017 Dec;43(12):1907-1909. doi: 10.1007/s00134-017-4956-0. Epub 2017 Oct 5. No abstract available.

PMID:
28983647
37.

Phospholipid composition of packed red blood cells and that of extracellular vesicles show a high resemblance and stability during storage.

Laurén E, Tigistu-Sahle F, Valkonen S, Westberg M, Valkeajärvi A, Eronen J, Siljander P, Pettilä V, Käkelä R, Laitinen S, Kerkelä E.

Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Jan;1863(1):1-8. doi: 10.1016/j.bbalip.2017.09.012. Epub 2017 Sep 28.

PMID:
28965917
38.

Clinical examination, critical care ultrasonography and outcomes in the critically ill: cohort profile of the Simple Intensive Care Studies-I.

Hiemstra B, Eck RJ, Koster G, Wetterslev J, Perner A, Pettilä V, Snieder H, Hummel YM, Wiersema R, de Smet AMGA, Keus F, van der Horst ICC; SICS Study Group.

BMJ Open. 2017 Sep 27;7(9):e017170. doi: 10.1136/bmjopen-2017-017170.

39.

Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults.

Cooper DJ, McQuilten ZK, Nichol A, Ady B, Aubron C, Bailey M, Bellomo R, Gantner D, Irving DO, Kaukonen KM, McArthur C, Murray L, Pettilä V, French C; TRANSFUSE Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group.

N Engl J Med. 2017 Nov 9;377(19):1858-1867. doi: 10.1056/NEJMoa1707572. Epub 2017 Sep 27. Erratum in: N Engl J Med. 2019 Aug 29;381(9):890.

40.

Assessment of plasma endostatin to predict acute kidney injury in critically ill patients.

Mårtensson J, Vaara ST, Pettilä V, Ala-Kokko T, Karlsson S, Inkinen O, Uusaro A, Larsson A, Bell M.

Acta Anaesthesiol Scand. 2017 Nov;61(10):1286-1295. doi: 10.1111/aas.12988. Epub 2017 Aug 31.

PMID:
28857121
41.

Plasma anti-FXa concentration after continuous intravenous infusion and subcutaneous dosing of enoxaparin for thromboprophylaxis in critically ill patients. A randomized clinical trial.

Vahtera A, Valkonen M, Huhtala H, Pettilä V, Kuitunen A.

Thromb Res. 2017 Oct;158:71-75. doi: 10.1016/j.thromres.2017.08.014. Epub 2017 Aug 24.

PMID:
28846877
42.

Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.

Kirkegaard H, Søreide E, de Haas I, Pettilä V, Taccone FS, Arus U, Storm C, Hassager C, Nielsen JF, Sørensen CA, Ilkjær S, Jeppesen AN, Grejs AM, Duez CHV, Hjort J, Larsen AI, Toome V, Tiainen M, Hästbacka J, Laitio T, Skrifvars MB.

JAMA. 2017 Jul 25;318(4):341-350. doi: 10.1001/jama.2017.8978.

43.

Fluid management in acute kidney injury.

Perner A, Prowle J, Joannidis M, Young P, Hjortrup PB, Pettilä V.

Intensive Care Med. 2017 Jun;43(6):807-815. doi: 10.1007/s00134-017-4817-x. Epub 2017 May 3. Review.

PMID:
28470347
44.

Renal recovery after acute kidney injury.

Forni LG, Darmon M, Ostermann M, Oudemans-van Straaten HM, Pettilä V, Prowle JR, Schetz M, Joannidis M.

Intensive Care Med. 2017 Jun;43(6):855-866. doi: 10.1007/s00134-017-4809-x. Epub 2017 May 2. Review.

45.

Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock.

Vilander LM, Kaunisto MA, Vaara ST, Pettilä V; FINNAKI study group.

Crit Care. 2017 Mar 8;21(1):47. doi: 10.1186/s13054-017-1631-3.

46.

Circulating chromogranin B levels in patients with acute respiratory failure: data from the FINNALI Study.

Myhre PL, Stridsberg M, Linko R, Okkonen M, Nygård S, Christensen G, Pettilä V, Omland T, Røsjø H; FINNALI Study Group.

Biomarkers. 2017 Dec;22(8):775-781. doi: 10.1080/1354750X.2016.1269200. Epub 2017 Jan 3.

PMID:
28049363
47.

Postoperative Cardiac Ischemia Detection by Continuous 12-Lead Electrocardiographic Monitoring in Vascular Surgery Patients: A Prospective, Observational Study.

Ollila A, Virolainen J, Vanhatalo J, Vikatmaa P, Tikkanen I, Venermo M, Salmenperä M, Pettilä V, Vikatmaa L.

J Cardiothorac Vasc Anesth. 2017 Jun;31(3):950-956. doi: 10.1053/j.jvca.2016.09.027. Epub 2016 Sep 28.

PMID:
27919716
48.

Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study.

Mildh H, Pettilä V, Korhonen AM, Karlsson S, Ala-Kokko T, Reinikainen M, Vaara ST; FINNAKI Study Group.

Ann Intensive Care. 2016 Dec;6(1):118. doi: 10.1186/s13613-016-0218-5. Epub 2016 Nov 29.

49.

A statistical analysis protocol for the time-differentiated target temperature management after out-of-hospital cardiac arrest (TTH48) clinical trial.

Kirkegaard H, Pedersen AR, Pettilä V, Hjort J, Rasmussen BS, de Haas I, Nielsen JF, Ilkjær S, Kaltoft A, Jeppesen AN, Grejs AM, Duez CH, Larsen AI, Toome V, Arus U, Taccone FS, Storm C, Laitio T, Skrifvars MB, Søreide E.

Scand J Trauma Resusc Emerg Med. 2016 Nov 28;24(1):138.

50.

Acute Kidney Injury After Cardiac Surgery by Complete KDIGO Criteria Predicts Increased Mortality.

Petäjä L, Vaara S, Liuhanen S, Suojaranta-Ylinen R, Mildh L, Nisula S, Korhonen AM, Kaukonen KM, Salmenperä M, Pettilä V.

J Cardiothorac Vasc Anesth. 2017 Jun;31(3):827-836. doi: 10.1053/j.jvca.2016.08.026. Epub 2016 Aug 26.

PMID:
27856153

Supplemental Content

Loading ...
Support Center